Sign in

CIK 0001651308

  • Large accelerated filer

BeOne Medicines Ltd.

Sign in to watch
Ticker
BEIGF
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
981209416
Phone
+41 616851900
Business address
C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
Former names
BeiGene, Ltd.

Securities

  • ONC American Depositary Shares Nasdaq
  • BEIGF Common stock OTC
  1. 4 Open-market sale CMO, Hematology sold 3,000 shares at $139.58 ($418,750)
  2. 4 Gift Director gave 89,999 shares (gift)
  3. 4 Gift Director gave 9,414 shares (gift)
  4. 4 Open-market sale Director sold 5,000 shares at an average $124.30 ($621,490)
  5. 4 Open-market sale CMO, Immuno-oncology sold 40,000 shares at an average $120.20 ($4,808,089)
  6. 4 Open-market sale CMO, Hematology sold 2,911 shares at $174.60 ($508,247)
  7. 4 Open-market sale Director sold 2,000 shares at $179.00 ($358,000)
  8. 4 Open-market sale CMO, Immuno-oncology sold 5,769 shares at an average $169.12 ($975,666)
  9. 4 Open-market sale Director sold 3,449 shares at an average $158.77 ($547,591)
  10. 4 Open-market buy Director bought 5,814,100 shares at $108.00 ($627,922,800)
  11. 4 Open-market sale Chief Executive Officer sold 2,550 shares at $164.12 ($418,497)
  12. 4 Grant or award Chief Executive Officer acquired 188,266 shares (grant or award)
  13. 4 Grant or award CFO & Chief Strategy Officer acquired 52,338 shares (grant or award)
  14. 4 Grant or award CMO, Hematology acquired 44,564 shares (grant or award)
  15. 4 Grant or award CMO, Immuno-oncology acquired 44,564 shares (grant or award)
  16. 4 Grant or award Director acquired 94,133 shares (grant or award)
  17. 4 Grant or award Director acquired 9,290 shares (grant or award)
  18. 4 Grant or award Director acquired 9,290 shares (grant or award)
  19. 4 Grant or award Director acquired 9,290 shares (grant or award)
  20. 4 Grant or award Director acquired 9,290 shares (grant or award)

Page 24 of 29 · 580 filings